Stoke Therapeutics, Inc. (STOK)
Form 4 sales, Form 144 notices and lockup dates
- Latest sale
- $17k
- Oct 2 · Routine
- Form 4 sales
- 131
- On record
- Form 144 notices
- 48
- Proposed sales
- Sold, last 30 days
- None
- No Form 4 sale
- Sold, last 90 days
- $214k
- 3 sales by 2 insiders
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- Oct 21, 2026Notice
Kaye Edward M. MD, Director, filed a notice to sell 1.5M shares
$38.4M1.5M shares
- Oct 2, 2026Routine
Allan Jonathan, GENERAL COUNSEL & CORP SEC, sold 3% of their holdings
$17k627 shares at $26.33
- Oct 2, 2026Notice
Allan Jonathan, GENERAL COUNSEL & CORP SEC, filed a notice to sell 627 shares
$16k627 shares
- Oct 1, 2026Routine
Ticho Barry, CHIEF MEDICAL OFFICER, sold 5.2% of their holdings
$27k1,051 shares at $26.16
- Sep 1, 2026Routine
Ticho Barry, CHIEF MEDICAL OFFICER, sold 21.6% of their holdings
$170k5,545 shares at $30.67
- Aug 18, 2026No plan
Allan Jonathan, GENERAL COUNSEL & CORP SEC, sold 11.9% of their holdings
$92k2,861 shares at $32.03
- Aug 18, 2026No plan
Ticho Barry, CHIEF MEDICAL OFFICER, sold 15.7% of their holdings
$153k4,767 shares at $32.03
- Aug 18, 2026No plan
Kaye Edward M. MD, Director, sold 9.2% of their holdings
$403k12,567 shares at $32.03
- Aug 3, 2026Routine
Ticho Barry, CHIEF MEDICAL OFFICER, sold 26% of their holdings
$208k7,176 shares at $29.04
- Aug 3, 2026Notice
Ticho Barry, CHIEF MEDICAL OFFICER, filed a notice to sell 20,967 shares
$605k20,967 shares
Every transaction
| Traded | Filed | Stock | Name | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 2, 2026 | Oct 2, 2026 | STOK | Allan Jonathan | GENERAL COUNSEL & CORP SEC | Sold | 627 | $26.33 | $17k | 20,598 | SEC |
| Oct 1, 2026 | Oct 2, 2026 | STOK | Ticho Barry | CHIEF MEDICAL OFFICER | Sold | 1,051 | $26.16 | $27k | 19,059 | SEC |
| Sep 23, 2026 | Sep 25, 2026 | STOK | Cumbo Alexander | Director | AwardedDirector Stock Option (Right to Buy) | 39,674 | 39,674 | SEC | ||
| Sep 1, 2026 | Sep 3, 2026 | STOK | Ticho Barry | CHIEF MEDICAL OFFICER | Sold | 5,545 | $30.67 | $170k | 20,110 | SEC |
| Aug 18, 2026 | Aug 18, 2026 | STOK | Allan Jonathan | GENERAL COUNSEL & CORP SEC | Sold | 2,861 | $32.03 | $92k | 21,225 | SEC |
| Aug 18, 2026 | Aug 18, 2026 | STOK | Ticho Barry | CHIEF MEDICAL OFFICER | Sold | 4,767 | $32.03 | $153k | 25,655 | SEC |
| Aug 18, 2026 | Aug 18, 2026 | STOK | Kaye Edward M. MD | Director | Sold | 12,567 | $32.03 | $403k | 124,557 | SEC |
| Aug 14, 2026 | Aug 18, 2026 | STOK | Allan Jonathan | GENERAL COUNSEL & CORP SEC | Exercised or settledPerformance Stock Units | 6,000 | 0 | SEC | ||
| Aug 14, 2026 | Aug 18, 2026 | STOK | Allan Jonathan | GENERAL COUNSEL & CORP SEC | Exercised options | 6,000 | 24,086 | SEC | ||
| Aug 14, 2026 | Aug 18, 2026 | STOK | Ticho Barry | CHIEF MEDICAL OFFICER | Exercised or settledPerformance Stock Units | 10,000 | 0 | SEC | ||
| Aug 14, 2026 | Aug 18, 2026 | STOK | Ticho Barry | CHIEF MEDICAL OFFICER | Exercised options | 10,000 | 30,422 | SEC | ||
| Aug 14, 2026 | Aug 18, 2026 | STOK | Kaye Edward M. MD | Director | Exercised or settledPerformance Stock Units | 26,250 | 0 | SEC | ||
| Aug 14, 2026 | Aug 18, 2026 | STOK | Kaye Edward M. MD | Director | Exercised options | 26,250 | 137,124 | SEC | ||
| Aug 3, 2026 | Aug 5, 2026 | STOK | Ticho Barry | CHIEF MEDICAL OFFICER | Sold | 7,176 | $29.04 | $208k | 20,422 | SEC |
| Jul 16, 2026 | Jul 17, 2026 | STOK | Harrison Seth Loring | Director | GiftStock Option (Right to Buy) | 303,190 | 17,786 | SEC | ||
| Jul 15, 2026 | Jul 17, 2026 | STOK | McCauley Thomas | Chief Scientific Officer | AwardedStock Option (Right to Buy) | 225,000 | 225,000 | SEC | ||
| Jul 1, 2026 | Jul 6, 2026 | STOK | Ticho Barry | CHIEF MEDICAL OFFICER | Sold | 7,228 | $32.66 | $236k | 27,598 | SEC |
| Jun 16, 2026 | Jun 18, 2026 | STOK | Allan Jonathan | GENERAL COUNSEL & CORP SEC | Sold | 1,457 | $29.95 | $44k | 18,086 | SEC |
| Jun 3, 2026 | Jun 5, 2026 | STOK | Krainer Adrian R. | Director | AwardedDirector Stock Option (Right to Buy) | 17,786 | 17,786 | SEC | ||
| Jun 3, 2026 | Jun 5, 2026 | STOK | Burstein Jennifer | Director | AwardedDirector Stock Option (Right to Buy) | 17,786 | 17,786 | SEC | ||
| Jun 3, 2026 | Jun 5, 2026 | STOK | Tzianabos Arthur | Director | AwardedDirector Stock Option (Right to Buy) | 17,786 | 17,786 | SEC | ||
| Jun 3, 2026 | Jun 5, 2026 | STOK | Smith Julie | Director | AwardedDirector Stock Option (Right to Buy) | 17,786 | 17,786 | SEC | ||
| Jun 3, 2026 | Jun 5, 2026 | STOK | Kaye Edward M. MD | Director | AwardedDirector Stock Option (Right to Buy) | 17,786 | 17,786 | SEC | ||
| Jun 3, 2026 | Jun 5, 2026 | STOK | Harrison Seth Loring | Director | AwardedDirector Stock Option (Right to Buy) | 17,786 | 17,786 | SEC | ||
| Jun 3, 2026 | Jun 5, 2026 | STOK | Levin Arthur A | Director | AwardedDirector Stock Option (Right to Buy) | 17,786 | 17,786 | SEC | ||
| Jun 1, 2026 | Jun 3, 2026 | STOK | Ticho Barry | CHIEF MEDICAL OFFICER | Sold | 1,795 | $30.58 | $55k | 34,826 | SEC |
| May 1, 2026 | May 5, 2026 | STOK | Ticho Barry | CHIEF MEDICAL OFFICER | Sold | 2,243 | $32.79 | $74k | 36,621 | SEC |
| Apr 3, 2026 | Apr 7, 2026 | STOK | Kahn Clare | Director | AwardedStock Option (Right to Buy) | 30,782 | 30,782 | SEC | ||
| Apr 1, 2026 | Apr 3, 2026 | STOK | Ticho Barry | CHIEF MEDICAL OFFICER | Sold | 1,838 | $32.66 | $60k | 38,864 | SEC |
| Mar 20, 2026 | Mar 24, 2026 | STOK | Allan Jonathan | GENERAL COUNSEL & CORP SEC | Sold | 9,293 | $33.69 | $313k | 19,543 | SEC |
| Mar 19, 2026 | Mar 19, 2026 | STOK | Ticho Barry | CHIEF MEDICAL OFFICER | Sold | 14,311 | $31.92 | $457k | 40,702 | SEC |
| Mar 19, 2026 | Mar 19, 2026 | STOK | Ticho Barry | CHIEF MEDICAL OFFICER | Exercised or settledStock Option (Right to Buy) | 1,365 | 83,035 | SEC | ||
| Mar 19, 2026 | Mar 19, 2026 | STOK | Ticho Barry | CHIEF MEDICAL OFFICER | Exercised options | 1,365 | $2.19 | $3k | 42,163 | SEC |
| Mar 18, 2026 | Mar 19, 2026 | STOK | Allan Jonathan | GENERAL COUNSEL & CORP SEC | Sold | 8,895 | $32.14 | $286k | 28,836 | SEC |
| Mar 18, 2026 | Mar 19, 2026 | STOK | Leggett Thomas | Chief Financial Officer | Sold | 4,578 | $32.14 | $147k | 10,172 | SEC |
| Mar 18, 2026 | Mar 19, 2026 | STOK | Hoitt Jason | Chief Patient Officer | Sold | 3,712 | $32.14 | $119k | 10,276 | SEC |
| Mar 15, 2026 | Mar 17, 2026 | STOK | Allan Jonathan | GENERAL COUNSEL & CORP SEC | Exercised or settledRestricted Stock Units | 25,475 | 36,000 | SEC | ||
| Mar 15, 2026 | Mar 17, 2026 | STOK | Allan Jonathan | GENERAL COUNSEL & CORP SEC | Exercised options | 25,475 | 37,731 | SEC | ||
| Mar 15, 2026 | Mar 17, 2026 | STOK | Ticho Barry | CHIEF MEDICAL OFFICER | Exercised or settledRestricted Stock Units | 33,850 | 32,250 | SEC | ||
| Mar 15, 2026 | Mar 17, 2026 | STOK | Ticho Barry | CHIEF MEDICAL OFFICER | Exercised options | 33,850 | 53,648 | SEC | ||
| Mar 15, 2026 | Mar 17, 2026 | STOK | Leggett Thomas | Chief Financial Officer | Exercised or settledRestricted Stock Units | 14,750 | 44,250 | SEC | ||
| Mar 15, 2026 | Mar 17, 2026 | STOK | Leggett Thomas | Chief Financial Officer | Exercised options | 14,750 | 14,750 | SEC | ||
| Mar 15, 2026 | Mar 17, 2026 | STOK | Hoitt Jason | Chief Patient Officer | Exercised or settledRestricted Stock Units | 10,000 | 30,000 | SEC | ||
| Mar 15, 2026 | Mar 17, 2026 | STOK | Hoitt Jason | Chief Patient Officer | Exercised options | 10,000 | 13,988 | SEC | ||
| Mar 15, 2026 | Mar 17, 2026 | STOK | Kaye Edward M. MD | Director | Exercised or settledRestricted Stock Units | 61,750 | 52,500 | SEC | ||
| Mar 15, 2026 | Mar 17, 2026 | STOK | Kaye Edward M. MD | Director | Exercised options | 61,750 | 110,874 | SEC | ||
| Mar 13, 2026 | Mar 17, 2026 | STOK | Levin Arthur A | Director | Sold | 605 | $36.80 | $22k | 4,237 | SEC |
| Mar 10, 2026 | Mar 12, 2026 | STOK | Krainer Adrian R. | Director | Sold | 33,243 | $39.74 | $1.3M | 283,302 | SEC |
| Mar 10, 2026 | Mar 12, 2026 | STOK | Tzianabos Arthur | Interim Executive Chair | Sold | 4,355 | $40.00 | $174k | 31,339 | SEC |
| Mar 10, 2026 | Mar 12, 2026 | STOK | Tzianabos Arthur | Interim Executive Chair | Exercised or settledStock Option (Right to Buy) | 3,955 | 118,696 | SEC |
Sales, notices and lockups (179)
Export watchlist as CSV| Source | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 21, 2026 | Oct 21, 2026 | Kaye Edward M. MD | STOK | Director | Form 144 notice | 1.5M | $38.4M | Notice | SEC | |
| Oct 2, 2026 | Oct 2, 2026 | Allan Jonathan | STOK | GENERAL COUNSEL & CORP SEC | Form 4 sale | 627 | $17k | 3.0% | Routine | SEC |
| Oct 2, 2026 | Oct 2, 2026 | Allan Jonathan | STOK | GENERAL COUNSEL & CORP SEC | Form 144 notice | 627 | $16k | Notice | SEC | |
| Oct 1, 2026 | Oct 2, 2026 | Ticho Barry | STOK | CHIEF MEDICAL OFFICER | Form 4 sale | 1,051 | $27k | 5.2% | Routine | SEC |
| Sep 1, 2026 | Sep 3, 2026 | Ticho Barry | STOK | CHIEF MEDICAL OFFICER | Form 4 sale | 5,545 | $170k | 21.6% | Routine | SEC |
| Aug 18, 2026 | Aug 18, 2026 | Allan Jonathan | STOK | GENERAL COUNSEL & CORP SEC | Form 4 sale | 2,861 | $92k | 11.9% | No plan | SEC |
| Aug 18, 2026 | Aug 18, 2026 | Ticho Barry | STOK | CHIEF MEDICAL OFFICER | Form 4 sale | 4,767 | $153k | 15.7% | No plan | SEC |
| Aug 18, 2026 | Aug 18, 2026 | Kaye Edward M. MD | STOK | Director | Form 4 sale | 12,567 | $403k | 9.2% | No plan | SEC |
| Aug 3, 2026 | Aug 5, 2026 | Ticho Barry | STOK | CHIEF MEDICAL OFFICER | Form 4 sale | 7,176 | $208k | 26.0% | Routine | SEC |
| Aug 3, 2026 | Aug 3, 2026 | Ticho Barry | STOK | CHIEF MEDICAL OFFICER | Form 144 notice | 20,967 | $605k | Notice | SEC | |
| Jul 1, 2026 | Jul 6, 2026 | Ticho Barry | STOK | CHIEF MEDICAL OFFICER | Form 4 sale | 7,228 | $236k | 20.8% | Routine | SEC |
| Jul 1, 2026 | Jul 1, 2026 | Ticho Barry | STOK | CHIEF MEDICAL OFFICER | Form 144 notice | 7,228 | $237k | Notice | SEC | |
| Jun 16, 2026 | Jun 18, 2026 | Allan Jonathan | STOK | GENERAL COUNSEL & CORP SEC | Form 4 sale | 1,457 | $44k | 7.5% | Routine | SEC |
| Jun 16, 2026 | Jun 16, 2026 | Allan Jonathan | STOK | GENERAL COUNSEL & CORP SEC | Form 144 notice | 1,457 | $44k | Notice | SEC | |
| Jun 1, 2026 | Jun 3, 2026 | Ticho Barry | STOK | CHIEF MEDICAL OFFICER | Form 4 sale | 1,795 | $55k | 4.9% | Routine | SEC |
| May 1, 2026 | May 5, 2026 | Ticho Barry | STOK | CHIEF MEDICAL OFFICER | Form 4 sale | 2,243 | $74k | 5.8% | Routine | SEC |
| May 1, 2026 | May 1, 2026 | Ticho Barry | STOK | CHIEF MEDICAL OFFICER | Form 144 notice | 4,038 | $132k | Notice | SEC | |
| Apr 1, 2026 | Apr 3, 2026 | Ticho Barry | STOK | CHIEF MEDICAL OFFICER | Form 4 sale | 1,838 | $60k | 4.5% | Routine | SEC |
| Apr 1, 2026 | Apr 1, 2026 | Ticho Barry | STOK | CHIEF MEDICAL OFFICER | Form 144 notice | 1,838 | $60k | Notice | SEC | |
| Mar 20, 2026 | Mar 24, 2026 | Allan Jonathan | STOK | GENERAL COUNSEL & CORP SEC | Form 4 sale | 9,293 | $313k | 32.2% | Routine | SEC |
| Mar 20, 2026 | Mar 20, 2026 | Allan Jonathan | STOK | GENERAL COUNSEL & CORP SEC | Form 144 notice | 9,293 | $308k | Notice | SEC | |
| Mar 19, 2026 | Mar 19, 2026 | Ticho Barry | STOK | CHIEF MEDICAL OFFICER | Form 4 sale | 14,311 | $457k | 26.0% | Routine | SEC |
| Mar 19, 2026 | Mar 19, 2026 | Ticho Barry | STOK | CHIEF MEDICAL OFFICER | Form 144 notice | 1,461 | $45k | Notice | SEC | |
| Mar 18, 2026 | Mar 19, 2026 | Allan Jonathan | STOK | GENERAL COUNSEL & CORP SEC | Form 4 sale | 8,895 | $286k | 23.6% | No plan | SEC |
| Mar 18, 2026 | Mar 19, 2026 | Leggett Thomas | STOK | Chief Financial Officer | Form 4 sale | 4,578 | $147k | 31.0% | Unusual | SEC |
| Mar 18, 2026 | Mar 19, 2026 | Hoitt Jason | STOK | Chief Patient Officer | Form 4 sale | 3,712 | $119k | 26.5% | Unusual | SEC |
| Mar 13, 2026 | Mar 17, 2026 | Levin Arthur A | STOK | Director | Form 4 sale | 605 | $22k | 12.5% | Routine | SEC |
| Mar 13, 2026 | Mar 13, 2026 | Levin Arthur A | STOK | Director | Form 144 notice | 605 | $22k | Notice | SEC | |
| Mar 10, 2026 | Mar 12, 2026 | Krainer Adrian R. | STOK | Director | Form 4 sale | 33,243 | $1.3M | 10.5% | Routine | SEC |
| Mar 10, 2026 | Mar 12, 2026 | Tzianabos Arthur | STOK | Interim Executive Chair | Form 4 sale | 4,355 | $174k | 12.2% | Routine | SEC |
| Mar 10, 2026 | Mar 10, 2026 | Tzianabos Arthur | STOK | Director | Form 144 notice | 90,508 | $3.5M | Notice | SEC | |
| Mar 2, 2026 | Mar 4, 2026 | Krainer Adrian R. | STOK | Director | Form 4 sale | 7,229 | $287k | 2.2% | Routine | SEC |
| Mar 2, 2026 | Mar 2, 2026 | Krainer Adrian R. | STOK | Director | Form 144 notice | 40,472 | $1.5M | Notice | SEC | |
| Dec 8, 2025 | Dec 10, 2025 | Allan Jonathan | STOK | GENERAL COUNSEL & CORP SEC | Form 4 sale | 3,978 | $128k | 25.2% | Routine | SEC |
| Dec 8, 2025 | Dec 10, 2025 | Kaye Edward M. MD | STOK | Director | Form 4 sale | 13,430 | $433k | 21.5% | Routine | SEC |
| Dec 8, 2025 | Dec 8, 2025 | Kaye Edward M. MD | STOK | Director | Form 144 notice | 13,430 | $415k | Notice | SEC | |
| Dec 8, 2025 | Dec 8, 2025 | Allan Jonathan | STOK | GENERAL COUNSEL & CORP SEC | Form 144 notice | 3,978 | $123k | Notice | SEC | |
| Dec 5, 2025 | Dec 5, 2025 | Kaye Edward M. MD | STOK | Director | Form 144 notice | 2,181 | $68k | Notice | SEC | |
| Dec 5, 2025 | Dec 5, 2025 | Allan Jonathan | STOK | GENERAL COUNSEL & CORP SEC | Form 144 notice | 7,781 | $242k | Notice | SEC | |
| Dec 5, 2025 | Dec 5, 2025 | Ticho Barry | STOK | CHIEF MEDICAL OFFICER | Form 144 notice | 1,989 | $62k | Notice | SEC | |
| Dec 5, 2025 | Dec 5, 2025 | Allan Jonathan | STOK | GENERAL COUNSEL & CORP SEC | Form 4 sale | 9,803 | $306k | 38.3% | Routine | SEC |
| Dec 5, 2025 | Dec 5, 2025 | Ticho Barry | STOK | CHIEF MEDICAL OFFICER | Form 4 sale | 5,358 | $167k | 21.3% | Routine | SEC |
| Dec 5, 2025 | Dec 5, 2025 | Kaye Edward M. MD | STOK | Director | Form 4 sale | 15,001 | $467k | 19.3% | Routine | SEC |
| Dec 3, 2025 | Dec 3, 2025 | Allan Jonathan | STOK | GENERAL COUNSEL & CORP SEC | Form 4 sale | 4,576 | $138k | 18.9% | No plan | SEC |
| Dec 3, 2025 | Dec 3, 2025 | Ticho Barry | STOK | CHIEF MEDICAL OFFICER | Form 4 sale | 4,020 | $121k | 21.0% | No plan | SEC |
| Dec 3, 2025 | Dec 3, 2025 | Kaye Edward M. MD | STOK | Director | Form 4 sale | 2,136 | $65k | 4.0% | No plan | SEC |
| Nov 24, 2025 | Nov 26, 2025 | Krainer Adrian R. | STOK | Director | Form 4 sale | 40,472 | $1.2M | 11.1% | Routine | SEC |
| Nov 24, 2025 | Nov 24, 2025 | Krainer Adrian R. | STOK | Director | Form 144 notice | 40,472 | $1.2M | Notice | SEC | |
| Nov 14, 2025 | Nov 18, 2025 | Krainer Adrian R. | STOK | Director | Form 4 sale | 40,472 | $1.1M | 10.0% | Routine | SEC |
| Nov 14, 2025 | Nov 14, 2025 | Krainer Adrian R. | STOK | Director | Form 144 notice | 40,472 | $1.1M | Notice | SEC |